Search

Your search keyword '"Christian Seitz"' showing total 51 results
Start Over Author "Christian Seitz" Journal european urology supplements
51 results on '"Christian Seitz"'

1. Tubeless PCNL - What is the evidence?

Author

M. Oezsoy, Julian Veser, Christian Seitz, and V. Jahrreis

Subjects
medicine.medical_specialty, business.industry, Urology, General surgery, Medicine, business
Published
2019

6. Response assessment using 68Ga-PSMA ligand PET-parameters in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration resistant prostate cancer

Author

Gero Kramer, Francesco Soria, M. Hartenbach, Alexander Haug, David D'Andrea, S. Pfaff, John W. Babich, Karl Hermann Grubmüller, Bernhard Grubmüller, S.F. Shariat, W. Wadsak, F. Berndl, M. Hacker, Theresa Balber, Pascal A. T. Baltzer, M. Mitterhauser, and Christian Seitz

Subjects
Response assessment, Prostate cancer, business.industry, Urology, Cancer research, Radioligand, 68ga psma, Medicine, In patient, Castration resistant, Ligand (biochemistry), business, medicine.disease
Published
2018

7. Neutrophil–lymphocyte ratio predicts pathological features and biochemical recurrence after radical prostatectomy

Author

S.F. Shariat, M. Özsoy, P.I. Karakiewicz, Gero Kramer, Francesco Soria, M. Rouprêt, Harun Fajkovic, Alberto Briganti, M. Moschini, Christian Seitz, and Tobias Klatte

Subjects
Biochemical recurrence, medicine.medical_specialty, medicine.anatomical_structure, Prostatectomy, business.industry, Urology, Lymphocyte, medicine.medical_treatment, medicine, business, Pathological
Published
2016

8. Medical Expulsive Therapy of Ureteral Calculi and Supportive Therapy After Extracorporeal Shock Wave Lithotripsy

Author

Christian Seitz

Subjects
Nephrology, medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, Context (language use), Shock wave lithotripsy, Lithotripsy, Extracorporeal shock wave lithotripsy, Extracorporeal, Surgery, Ureter, medicine.anatomical_structure, Supportive psychotherapy, Internal medicine, medicine, business
Abstract

Context Medical expulsive therapy (MET) augments expulsion rates and reduces colic events. Therefore, MET is an appropriate procedure to facilitate stone passage during the observation period in patients who have a newly diagnosed ureteral stone and whose symptoms are controlled. Increasing evidence indicates that supportive therapy following shock wave lithotripsy (SWL) for urolithiasis is also effective. Objective Our aim was to summarize the literature on MET in the treatment of urolithiasis. Evidence acquisition This paper is based on a presentation given at the symposium "Terpenes in Urolithiasis" that was held in Dusseldorf, Germany, in 2010. Evidence synthesis MET with α-blockade and calcium channel blockade resulted in accelerated and higher expulsion rates compared with a control group. Higher expulsion rates were demonstrated for the entire ureter, although the vast majority of studies only included distally located stones. MET showed favorable results for renal stones after extracorporeal SWL. The number of necessary analgesic rescue medications, colic episodes, and hospital admissions during treatment periods was reduced. Conclusions MET facilitates ureteral stone passage during the observation period in patients who have a newly diagnosed ureteral stone

Published
2010

9. Staging performance and clinical impact of 68Ga-PSMA 11 ligand PET/MRI for primary diagnosed prostate cancer

Author

Martin Susani, M. Hartenbach, Sabrina Hartenbach, Pascal A. T. Baltzer, David D'Andrea, Harun Fajkovic, M. Hacker, S.F. Shariat, Gregor Goldner, P. Mazal, Bernhard Grubmüller, Christian Seitz, and Alexander Haug

Subjects
Oncology, Prostate cancer, medicine.medical_specialty, business.industry, Urology, Internal medicine, medicine, medicine.disease, Ligand (biochemistry), business, 68Ga-PSMA-11
Published
2018

10. 68 Ga-PSMA 11 ligand PET/CT and PET/MRI in patients with biochemical recurrence after definitive treatment for clinically non-metastatic prostate cancer – detection and impact on therapeutic management

Author

S. Korn, Alexander Haug, M. Hartenbach, Karl Hermann Grubmüller, David D'Andrea, Harun Fajkovic, Christian Seitz, P. Mazal, Martin Susani, Bernhard Grubmüller, Gregor Goldner, S.F. Shariat, Pascal A. T. Baltzer, M. Hacker, and Gero Kramer

Subjects
Biochemical recurrence, PET-CT, Prostate cancer, medicine.medical_specialty, business.industry, Urology, Medicine, Non metastatic, In patient, Radiology, business, medicine.disease, Ligand (biochemistry)
Published
2017

15. Immediate Treatment after PSA Progression

Author

Christian Seitz, Bob Djavan, and M. Remzi

Subjects
Oncology, medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Cryotherapy, Disease, Nomogram, urologic and male genital diseases, medicine.disease, Surgery, Radiation therapy, Prostate-specific antigen, Prostate cancer, Internal medicine, medicine, Hormone therapy, business
Abstract

This review of the recent international literature updates the knowledge about the diagnostic procedures used in prostate-specific antigen (PSA) progression following radical treatments of clinically localized prostate cancer. Prostate-specific antigen (PSA) progression in these patients is a common problem facing both the patient and the urologist. Not all patients with relapsing disease have an equal risk of morbidity and death due to prostate cancer. After surgery, biochemical failure can be defined as persisting detectable levels of PSA after radical prostatectomy or a PSA rise after a period of normalization. On the other hand, definitions of PSA progression after radiation therapy vary and no clear consensus can be found. Predictors of progression are precised leading to a better patient selection, based on currently available tables and nomograms. Indeed, identification of high risk patients may allow a more appropriate treatment decision. After radical treatment, the analysis of time to recurrence, PSA doubling time, PSA kinetics combined to modern imaging techniques may allow a better identification of the recurrence site. Thus, an optimal treatment strategy such as local irradiation, salvage surgery, hormone therapy or combinations for which indications and results are provided may be envisaged. Alternative options such as cryotherapy still need further investigation.

Published
2005

17. 692 Systematic review of tract sizes in miniaturized percutaneous nephrolithotomy

Author

Aleš Petřík, Y.C. Yuan, Andreas Skolarikos, Christian Seitz, Kemal Sarica, Steven MacLennan, Michael Straub, Yasir Ruhayel, Thomas Knoll, Saeed Dabestani, Abdulkadir Tepeler, and Christian Türk

Subjects
medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, medicine, Percutaneous nephrolithotomy, business, Surgery
Published
2016

18. 214 Prognostic significance of markers of systemic inflammatory response in patients with non-muscle invasive bladder cancer

Author

Malte Rieken, P.I. Karakiewicz, E.N. Xylinas, Christian Seitz, M. Rouprêt, Tobias Klatte, Ilaria Lucca, Aurélie Mbeutcha, Romain Mathieu, S.F. Shariat, Alberto Briganti, and M. Rink

Subjects
Oncology, medicine.medical_specialty, Bladder cancer, business.industry, Urology, Internal medicine, Inflammatory response, medicine, In patient, business, Non muscle invasive, medicine.disease
Published
2016

19. 647 The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: Validation and meta-analysis

Author

M. Rouprêt, P.I. Karakiewicz, Yair Lotan, Ilaria Lucca, Luis A. Kluth, Harun Fajkovic, Christian Seitz, Marek Babjuk, Tobias Klatte, M. De Martino, Malte Rieken, Alberto Briganti, S.F. Shariat, and Romain Mathieu

Subjects
Cystectomy, medicine.medical_specialty, Prognostic factor, business.industry, Urology, Meta-analysis, medicine.medical_treatment, Medicine, Neutrophil to lymphocyte ratio, business, Urothelial carcinoma
Published
2015

20. 474 Pathologic nodal staging scores (pNSS) for prostate cancer: A decision tool for adjuvant therapy after radical prostatectomy

Author

Yair Lotan, P. Schramek, S.F. Shariat, E.N. Xylinas, Maxine Sun, Niccolo Passoni, Luis A. Kluth, Firas Abdollah, M. Graefen, Felix K.-H. Chun, Douglas S. Scherr, T. Faison, Harun Fajkovic, Michael Herman, P.I. Karakiewicz, A. Tewari, Alberto Briganti, Marianne Schmid, and Christian Seitz

Subjects
Oncology, Decision tool, medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Nodal staging, medicine.disease, Prostate cancer, Internal medicine, medicine, Adjuvant therapy, business
Published
2013

21. 813 Time to disease recurrence is a strong predictor of cancer-specific mortality in upper tract urothelial carcinoma

Author

Wassim Kassouf, S.F. Shariat, Jay D. Raman, J.I. Martínez-Salamanca, E.N. Xylinas, Daniel Sjöberg, Eugene K. Cha, Yair Lotan, Vitaly Margulis, Eiji Kikuchi, G. Novara, Armin Pycha, Felix K.-H. Chun, Andrew J. Vickers, Luis A. Kluth, Douglas S. Scherr, Richard Zigeuner, Christian Seitz, M. Remzi, Karim Bensalah, and M. Rink

Subjects
Oncology, medicine.medical_specialty, Upper tract, business.industry, Urology, Internal medicine, Medicine, Disease, business, Cancer specific mortality, Urothelial carcinoma
Published
2013

22. 78 Impact of renal function on eligibility for chemotherapy and survival in patients who underwent radical nephroureterectomy

Author

F. Montorsi, S.F. Shariat, Yair Lotan, E.N. Xylinas, Richard K. Lee, Armin Pycha, Vitaly Margulis, Christian Seitz, Luis A. Kluth, Marc Zerbib, V. Ficarra, G. Novara, Alon Z. Weizer, P.I. Karakiewicz, Jay D. Raman, M. Rink, Douglas S. Scherr, Q-D. Trinh, M. Rouprêt, and Evi Comploj

Subjects
medicine.medical_specialty, Chemotherapy, business.industry, Urology, medicine.medical_treatment, medicine, Renal function, In patient, business, Surgery
Published
2013

24. 1067 Post-ureteroscopic lesion scale: Multicentre video-based evaluation of inter-rater reliability

Author

Thomas Knoll, Oliver W. Hakenberg, John D. Denstedt, E.N. Liatsikos, O. Traxer, A. Miernik, Alberto Trinchieri, Thorsten Bach, Franklin E. Kuehhas, Kemal Sarica, Benjamin W. Turney, Noor Buchholz, Christian Bach, H. Ather, P. Liske, Martin Schoenthaler, Erik Farin, Ralf Herwig, Michael Straub, José Manuel Reis-Santos, Palle Jørn Sloth Osther, Christian Seitz, M. Grasso, and H.M. Fritsche

Subjects
Lesion, medicine.medical_specialty, Inter-rater reliability, Physical medicine and rehabilitation, Scale (ratio), business.industry, Urology, medicine, medicine.symptom, business, Video based
Published
2013

25. 723 Clinical nodal staging scores for prostate cancer: A proposal for preoperative risk assessment

Author

Evanguelos Xylinas, Behfar Ehdaie, Alexander Bachmann, Harun Fajkovic, S.F. Shariat, Christian Seitz, Alessandro Nonis, Jens Hansen, Karl Pummer, Sascha Ahyai, Yair Lotan, Malte Rieken, Maxine Sun, M. Graefen, Luis A. Kluth, Douglas S. Scherr, Michael Herman, P.I. Karakiewicz, Armin J. Becker, F. Montorsi, Richard K. Lee, D. Seiler, P. Schramek, Wolfgang Loidl, Mithat Gonen, Firas Abdollah, A. Tewari, and Alberto Briganti

Subjects
Prostate cancer, medicine.medical_specialty, business.industry, Urology, Preoperative risk, medicine, Nodal staging, Radiology, medicine.disease, business
Published
2014

26. 166 External validation of the pathological nodal staging score for prostate cancer in a contemporary cohort: A population-based study

Author

Alexander Bachmann, S.F. Shariat, P.I. Karakiewicz, Alberto Briganti, E.N. Xylinas, Harun Fajkovic, Luis A. Kluth, Malte Rieken, Mithat Gonen, and Christian Seitz

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, External validation, Nodal staging, medicine.disease, Population based study, Prostate cancer, Internal medicine, Cohort, Medicine, business, Pathological
Published
2014

27. 876 Comparative analyses of surgical modalities for the management of prostate cancer: A multi-institutional study of positive surgical margin rates on 22,403 patients operated on in the new millennium

Author

Alexandre Mottrie, Phillip D. Stricker, E.W. Steyerburg, Péter Nyirády, Christopher G. Eden, David E. Neal, Thomas E. Ahlering, Andreas Nilsson, David I. Lee, S.F. Shariat, A. Tewari, Kevin M. Slawin, Stefan Carlsson, I. Heus, Aneesh Srivastava, Christian Seitz, N. Kraischits, Peter Wiklund, G. Novara, Tommy Nyberg, R. Sanchez-Salas, Douglas Skarecky, M. Rink, Thomas F. Chromecki, Monique J. Roobol, Felix K.-H. Chun, Xavier Cathelineau, and Prasanna Sooriakumaran

Subjects
Management of prostate cancer, medicine.medical_specialty, Modalities, business.industry, Urology, General surgery, medicine, Positive Surgical Margin, business, Surgery
Published
2012

28. 976 A multi-institutional study comparing biochemical recurrence rates on 20,614 patients operated on in the new millennium

Author

Christopher G. Eden, David E. Neal, G. Novara, Tommy Nyberg, S.F. Shariat, E.W. Steyerburg, N. Kraischits, R. Sanchez-Salas, Phillip D. Stricker, Alexandre Mottrie, Thomas E. Ahlering, Aneesh Srivastava, M. Rink, Christian Seitz, Kevin M. Slawin, Stefan Carlsson, A. Tewari, David I. Lee, Monique J. Roobol, I. Heus, Thomas F. Chromecki, Felix K.-H. Chun, Douglas Skarecky, Xavier Cathelineau, Andreas Nilsson, Prasanna Sooriakumaran, Peter Wiklund, and Péter Nyirády

Subjects
Biochemical recurrence, medicine.medical_specialty, business.industry, Urology, General surgery, medicine, business
Published
2012

31. 586 PROSPECTIVE RANDOMIZED MULTICENTER TRIAL COMPARING PROSTATE CANCER DETECTION RATES OF END FIRE AND SIDE FIRE TRANSRECTAL ULTRASOUND PROBE CONFIGURATION: INTERIM RESULTS

Author

Michael Marberger, Christian Seitz, Armin Pycha, Andreas Reissigl, Tobias Klatte, C. Wiunig, M. Remzi, and Matthias Waldert

Subjects
medicine.medical_specialty, Prostate cancer, Ultrasound probe, business.industry, Urology, Interim, Multicenter trial, medicine, Radiology, Detection rate, business, medicine.disease
Published
2010

32. 37 VALIDATION OF TUMOUR ARCHITECTURE IS AN INDEPENDENT PREDICTOR OF OUTCOMES AFTER RADICAL NEPHROURETERECTOMY

Author

Christian Seitz, Thomas J. Walton, S. Baba, S.F. Shariat, G. Novara, Stefan Tritschler, Patrick J. Bastian, Kazumasa Matsumoto, V. Ficarra, A. Gupta, P.I. Karakiewicz, M. Burger, Wassim Kassouf, H.M. Fritsche, Wolfgang Otto, and J. Carballido

Subjects
medicine.medical_specialty, business.industry, Urology, General surgery, medicine, Independent predictor, business
Published
2010

36. EIGHT-YEAR MULTICENTRE EUROPEAN POOLED ANALYSIS OF CLINICAL AND URODYNAMIC OUTCOME AND RETREATMENT RATES OF HIGH-ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY

Author

Stephan Hruby, Michael Marberger, Vincent Ravery, Christian Seitz, Mike Harik, Bob Djavan, S. Marihart, Amir V. Kaisary, S. Alavi, Matthias Waldert, and P. Dobronski

Subjects
medicine.medical_specialty, High energy, Pooled analysis, business.industry, Transurethral microwave thermotherapy, Urology, medicine.medical_treatment, medicine, business, Surgery
Published
2006

39. BENIGN PROSTATIC HYPERPLASIA SPECIMENS DERIVED FROM PATIENTS AFTER URINARY RETENTION SHOW SIGNIFICANTLY MORE PROSTATE GLANDS WITH UPREGULATION OF HLA-DR AND LOSS OF CD38 THAN THOSE DERIVED FROM PATIENTS WITHOUT URINARY RETENTION

Author

Kristian Hrachowitz, Michael Marberger, Gero Kramer, M. Dieter, and Christian Seitz

Subjects
medicine.medical_specialty, business.industry, Urinary retention, Urology, Hyperplasia, CD38, medicine.disease, medicine.anatomical_structure, Downregulation and upregulation, Prostate, HLA-DR, medicine, medicine.symptom, business
Published
2006

44. 177 Power colour doppler transrectal ultrasound (PCD-TRUS) can replace biopsy of the anastomotic region in detecting local recurrence following radical prostatectomy

Author

Christian Seitz, T. Anagnestou, Alexandre R. Zlotta, Claude Schulman, Michael Dobrovits, Bob Djavan, Georg Bartsch, Wolfgang Horninger, and Michael Marberger

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Ultrasound, Anastomosis, Biopsy, medicine, Colour doppler, Radiology, business
Published
2004

45. 562 Long term clinical and urodynamical outcome and retreatment rates of high energy transurethral microwave thermotherapy: Multicentre European pooled analysis with 6 years follow up

Author

Bob Djavan, Matthias Waldert, Michael Marberger, Amir V. Kaisary, Christian Seitz, G. Bartsch, Stephan Hruby, Wolfgang Horninger, S. Alavi, and P. Dobronski

Subjects
High energy, medicine.medical_specialty, Pooled analysis, Transurethral microwave thermotherapy, business.industry, Urology, medicine.medical_treatment, medicine, business, Term (time), Surgery
Published
2004

47. Time to recurrence PSA doubling time (PSADT), colour doppler enhanced trus accurately predict local recurrence following radical prostatectomy: Results of a prospective multiinstitutional biopsy controlled study

Author

Michael Marberger, T. Anagnostou, Mike Harik, Christian Seitz, Wolfgang Horninger, Georg Bartsch, Gero Kramer, M. Bemzi, Stephan Hruby, and Bob Djavan

Subjects
medicine.medical_specialty, Time to recurrence, medicine.diagnostic_test, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Biopsy, Colour doppler, medicine, Doubling time, business
Published
2003

49. The Vienna nomograms versus standard octant biopsies and repeat biopsies: A novel biopsy strategy defining the optimal number of cores based on PSA, age and prostate volume significantly improves cancer

Author

T. Anagnostou, H. Dobrovits, Michael Marberger, Christian Seitz, Bob Djavan, M. Remzi, and Mike Harik

Subjects
medicine.medical_specialty, Pathology, medicine.diagnostic_test, business.industry, Urology, Cancer, Octant (solid geometry), Nomogram, medicine.disease, medicine.anatomical_structure, Prostate, Biopsy, Medicine, Radiology, business, Volume (compression)
Published
2003

Catalog

Books, media, physical & digital resources
See catalog results